<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>57e4a27c-ac06-49fd-b52c-df497138f9a8</id>
  <name>AHS OGR ADULT CDEP Heparin Protocol for VTE Treatment</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.EPIC ID</key>
        <value>&lt;p&gt;OSQ&amp;nbsp;607650&lt;/p&gt;</value>
      </item>
      <item>
        <key>Technical.ï»© Technical Traceability</key>
        <value>{~AHSID~57e4a27c-ac06-49fd-b52c-df497138f9a8~NAME~AHS OGR ADULT CDEP Heparin Protocol for VTE Treatment}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;In order to avoid the higher risk of heparin-induced thrombocytopenia (HIT), it is recommended that the use of unfractionated heparin should be restricted to those with creatinine clearance less than 20 milliliters/minute (mL/min) imminent need for spinal invasion (neuraxial blockade or spinal tap), other major surgery with high bleeding risk or consider for use in arterial stroke or CVST.&lt;br&gt;&amp;nbsp;&lt;br&gt;PTT-based heparin infusions are unavailable at these 6 Edmonton zone sites: UAH, CCI, RAH, SGH, MIS, GNH. If you are ordering for a patient at one of these sites, choose the Anti-Xa based heparin infusion instead.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;u&gt;&lt;strong&gt;-&amp;nbsp;Connect Care Manual - Heparin Protocols&lt;/strong&gt;&lt;/u&gt;&lt;/p&gt;&lt;p&gt;(URL:&amp;nbsp;https://ahsweb.ca/HEE/ProtocolledOrders)&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Heparin Protocol for VTE Treatment">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" template_id="00e655f8-f9c0-40ad-9113-179d537a968a" concept_name="Heparin Infusion with Bolus and Re-Bolus and Anti-Xa Monitoring Adult Order Group" max="1" path="/items" name="Heparin infusion with bolus and re-bolus and Anti-Xa monitoring"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" template_id="187b5e3f-e4b1-40c0-8aea-760315d70b54" concept_name="Heparin Infusion with Bolus and Re-Bolus and PTT Monitoring Adult Order Group" max="1" path="/items" name="Heparin infusion with bolus and re-bolus and PTT monitoring"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.quantityorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">22AFA84E6D7935A3623EDFA7C2EB6D65</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.booleanorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">56B5A2F2979B94F83C97E66B46679692</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.datetimeorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">37AE50193A7EA542A4F219FF051EE95B</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
</template>